An old COVID-19 variant called A.30—which is exceedingly rare—“efficiently evades” antibodies induced by the Pfizer-BioNTech and AstraZeneca vaccines, according to a team of scientists in Germany. Only five cases of the A.30 variant have been reported so far worldwide, according to the COVID-19 variant tracking network GISAID. Three of these were in Angola, and one…
Rare A.30 COVID-19 Variant ‘Efficiently Evades’ Pfizer, AstraZeneca Vaccines: Study
AstraZeneca Says Drug Cocktail Effective Against COVID-19 in Late-Stage Study
European drugmaker AstraZeneca this week said a late-stage study showed its antibody drug cocktail is effective at keeping COVID-19 patients out of hospitals. The phase 3 trial preliminary results showed the drug, a long acting antibody (LAAB) combination, cut the risk of developing severe COVID-19 or dying by 50 percent compared to a placebo in people…
NTD Business Full Broadcast (Oct. 5)
AstraZeneca seeks approval for its new drug, which utilizes antibodies—for a potential alternative to vaccination. In a record-high trade deficit, Americans bought more foreign goods and services than ever in August. What does that say about the economy? In China, another real estate company says it can’t pay its debts, fueling concerns about China’s property…
AstraZeneca Seeks US Authorization for COVID-19 Preventive Treatment
A European biotechnology firm on Tuesday announced it’s seeking emergency authorization of a treatment it says can prevent symptomatic COVID-19. AstraZeneca said it submitted an emergency use authorization (EUA) request for an antibody combination drug dubbed AZD7442. “Vulnerable populations such as the immunocompromised often aren’t able to mount a protective response following vaccination and continue…
AstraZeneca Says Its COVID-19 Vaccine Is 74 Percent Effective in US Testing
AstraZeneca’s COVID-19 vaccine is 74 percent effective in preventing symptomatic illness, according to data from its U.S. clinical trial published in the New England Journal of Medicine on Wednesday. The phase 3 trial involved more than 32,000 participants in the United States, Peru, and Chile, who either received two doses of the COVID-19 vaccine or…
AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
September 29, 2021
admin
AstrazenecaBusiness & EconomyCaelumCompaniesdealdrugmakereconomyLocal NewsRegional-Local NewsUKUSUS NewsWorld
0 Comment
AstraZeneca will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker said on Wednesday, sharpening its focus on rare-disease drugs following its purchase of Alexion Pharmaceuticals. The deal gives AstraZeneca access to another potentially lucrative rare disease drug that is undergoing late-stage trials and has a “fast track”…
AstraZeneca Invests in Imperial’s Self-Amplifying RNA Technology With Eye on Future Drugs
LONDON—AstraZeneca Plc on Thursday struck a deal with the firm behind Imperial College London’s experimental COVID-19 vaccine to develop and sell drugs based on its self-amplifying RNA technology platform in other disease areas. Under the deal, VaxEquity, a startup founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are…
EU Regulator Unable to Confirm If Women Face Increased Clot Risks After AstraZeneca Shot
Europe’s drug regulator said on Friday that it could not confirm whether AstraZeneca’s COVID-19 vaccine has any influence on higher risks for unusual blood clots associated with low levels of blood platelets in women and younger adults. The European Medicine Agency (EMA) said in a statement it was requested by the European Commission to provide…
‘Roll Up, Roll Up’: Premier Announces Super Pfizer Weekend Vaccination Push
Queensland Premier Annastacia Palaszczuk has announced a “Super Pfizer Weekend” in a bid to increase vaccine coverage as the rollout in her state lags behind the rest of Australia. The expanded vaccine rollout comes as more Pfizer supplies arrive, with about 38 percent of Queenslanders currently fully vaccinated and around 57 percent with one dose….
Poland to Donate 400,000 Doses of AstraZeneca Vaccine to Taiwan
WARSAW—Poland will donate 400,000 doses of the AstraZeneca Plc COVID-19 vaccine to Taiwan, the foreign ministry in Warsaw said on Saturday, to help boost vaccination rates in the country. While a relatively small domestic coronavirus outbreak is well under control in Taiwan, only around 5 percent of its 23.5 million population are fully vaccinated, though…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`